Recruiting

Telehealth and Remote Blood Pressure

ClinicalTrials.gov IDNCT07356518

PhaseNA

Enrollment60

SponsorWake Forest University Health Sciences

Age18 Years

SexFEMALE

I'm interested View official listing

Conditions studied

Hypertension, Hypertension in Pregnancy

About this study

The purpose of this research study is to compare the management of chronic hypertension during pregnancy using telehealth visits with blood pressure telemonitoring and health coaching as compared to standard in person clinic visits. The study involves pregnant woman aged 18-45 who are receiving care for chronic hypertension. Participation in this research study will last until their baby is delivered. The number of in-person clinic visits depends on the participant's treatment assignment. Those assigned to telehealth visits will have telehealth visits alternating with clinic visits every two weeks until the end of pregnancy week 31. Those assigned to telehealth visits will also have five sessions with a health coach via telephone or video from the time of enrollment until the end of pregnancy week 36.

Interventions

Behavioral: Telehealth visits — remote visits with participants
Behavioral: In-person visits — standard of care visits with care provider in person

Primary outcomes

Feasibility of telehealth with remote BP telemonitoring compared to standard care (Gestational Week 31)
Safety of telehealth combined with telemonitoring compared to standard care (Gestational Week 31)

Eligibility information

Inclusion Criteria: * prior diagnosis of Chronic hypertension (cHTN) * Pregnant women * Known: documented diagnosis or on antihypertensive medication prior to pregnancy Exclusion Criteria: * Any significant chronic medical or psychiatric illness that, in the investigator's opinion, would prevent participation in the study * Cardiac disorders: cardiomyopathy, angina, Coronary Artery Disease (CAD) * Current substance abuse disorder * Multifetal pregnancy * Participation in another study without prior approval * Plan to deliver outside Atrium Health Wake Forest Baptist * Prior stroke * Severe hypertension * Suspected or known fetal major structural/chromosomal abnormality or fetal demise

Study locations

Wake Forest University Health Sciences, Winston-Salem, North Carolina 27157 United States

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.